Groupe la Francaise’s SpringWorks Therapeutics SWTX Stock Holding History

Groupe la Francaise’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-163,935	Closed	-$7.7M	–	821
2025 Q2	$7.7M	Buy	+163,935	New	+$7.29M	0.12%	106

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Groupe la Francaise's SWTX Position: Q3 2025 in Review

Groupe la Francaise sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 163,935 shares — an estimated $7.7M sold.

Groupe la Francaise first reported a position in SWTX in Q2 2025 and held it in 1 quarter. The position peaked at $7.7M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Groupe la Francaise reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Groupe la Francaise sold 163,935 SpringWorks Therapeutics shares in Q3 2025, an estimated $7.7M.
Groupe la Francaise first reported a position in SpringWorks Therapeutics in Q2 2025 and held it in 1 quarter.
Groupe la Francaise's SpringWorks Therapeutics position peaked at $7.7M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Groupe la Francaise's 13F filing for Q3 2025, filed 13 Nov 2025.